C

Cocrystal Pharma
D

COCP

2.22000
USD
0.10
(4.72%)
Market Closed
Volume
37
EPS
-2
Div Yield
-
P/E
-1
Market Cap
22,585,814
OverviewSignalsIdeasNews
Related Instruments
    A
    AUPH
    -0.20500
    (-2.46%)
    8.12000 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    T
    TRVN
    -2.02000
    (-44.99%)
    2.47000 USD
    V
    VBIV
    0
    (0%)
    0.000000 USD
    More
News

Title: Cocrystal Pharma

Sector: Healthcare
Industry: Biotechnology
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).